Wedbush Equities Analysts Lift Earnings Estimates for ANRO
Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) – Investment analysts at Wedbush boosted their Q2 2025 earnings estimates for Alto Neuroscience in a research note issued on Thursday, May 15th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($0.68) for the quarter, up from their prior estimate of […]
